Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
RN7SK pseudogene 205 is a noncoding RNA pseudogene related to the functional RN7SK small nuclear RNA. While RN7SK is an abundant small nuclear RNA in metazoans essential for regulating RNA polymerase II elongation and gene expression[3][1][4], RN7SKP205 itself does not encode a functional product and is not considered a therapeutic target or biomarker. The biological roles, disease relevance, and drug interactions described for RN7SK do not apply to RN7SKP205, which is most likely a nonfunctional genomic relic. Key clarification: - All functional and research-relevant information concerns RN7SK (the small nuclear RNA), not RN7SKP205. - RN7SKP205 should not be considered a valid target for therapeutic or diagnostic purposes; it is just a genomic pseudogene variant of RN7SK. - For any structured molecular target information, focus on RN7SK small nuclear RNA or RN7SK, not its pseudogenes.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on RN7SK pseudogene 205 (RN7SKP205).